EMA Application withdrawn: Ekesivy (diclofenamide) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

EMA has withdrawn the application for Ekesivy (diclofenamide) by Sun Pharmaceutical Industries Europe B.V.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Periodic Paralysis

Drugs mentioned

• Ekesivy (diclofenamide)

Snippet

Status: Application withdrawn. Therapeutic area: Paralyses, Familial Periodic. MAH: Sun Pharmaceutical Industries Europe B.V.